摘要
理论上,阿司匹林在糖尿病心血管病防治中是有效的,但对其在临床应用中的益处及风险目前仍存争议。基于现有临床证据,既往无心血管病的低危糖尿病患者不能从阿司匹林一级预防中获益。本综述探讨阿司匹林在糖尿病患者心血管事件一级预防中的真实价值。
Aspirin is effective in prevention and treatment for diabetic cardiovascular disease.However,its benefit and risk in clinical application are disputed.Based on clinical observation,low-risk diabetic patients without cardiovascular disease can not benefit from aspirin in the primary prevention.In this review,an evaluation of aspirin in the primary prevention of cardiovascular events in diabetic patients is explored.
出处
《世界临床药物》
CAS
2013年第3期152-157,共6页
World Clinical Drug
关键词
阿司匹林
糖尿病
一级预防
心血管事件
aspirin
diabetes
primary prevention
cardiovascular event
